Serum fetuin-A and RANKL levels in patients with early stage breast cancer

Serum fetuin-A and RANKL levels in patients with early stage breast cancer

Background: Breast cancer (BC) is the primary cause of mortality due to cancer in females around the world. Fetuin-A is known to increase metastases over signals and peroxisomes related with growing. Receptor activator of nuclear factor-kB ligand (RANKL) takes part in cell adhesion, and RANKL inhibi...

Full description

Bibliographic Details
Main Authors: Afsar Cigdem Usul, Aral Hale, Can Orçun, Can Trabulus Didem, Karacetin Didem, Ali Nazlı Mehmet, Umar Gursu Rıza, Karabulut Senem
Format: Article
Language:English
Published: Society of Medical Biochemists of Serbia, Belgrade 2023-01-01
Series:Journal of Medical Biochemistry
Subjects:
breast cancer
fetuin-a
rankl
serum
Online Access:https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2023/1452-82582302249A.pdf

Similar Items

Similar Items